Medifast provided earnings guidance for the first quarter of 2024. For the period, the company expects revenue to be in the range of $155 million to $175 million and diluted EPS to be in the range of $0.25 to $0.95.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.53 USD | +0.57% | -3.27% | -63.51% |
Apr. 30 | Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT |
Apr. 30 | Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.51% | 262M | |
+15.92% | 8.35B | |
+3.37% | 7.62B | |
+1.49% | 6.01B | |
-5.33% | 3.75B | |
-7.57% | 3.7B | |
-2.94% | 1.34B | |
-26.08% | 1.13B | |
+14.95% | 992M | |
-9.40% | 925M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- Medifast Provides Earnings Guidance for the First Quarter of 2024